Duncker Streett & CO Inc Abbott Laboratories Transaction History

Duncker Streett & CO Inc

$542 Million
Q3 2024

A detailed history of Duncker Streett & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Duncker Streett & CO Inc holds 36,871 shares of ABT stock, worth $4.34 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

36,871

Previous 36,787 0.23%

Holding current value

$4.34 Million

Previous $3.82 Million 9.97%

% of portfolio

0.78%

Previous 0.74%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $8,405 - $9,922	84 Added 0.23%	36,871 $4.2 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $129,438 - $144,485	-1,285 Reduced 3.38%	36,787 $3.82 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $138,871 - $153,377	-1,268 Reduced 3.22%	38,072 $4.33 Million
Q4 2023 Jan 30, 2024	BUY	$90.19 - $110.4 $450 - $552	5 Added 0.01%	39,340 $4.33 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $2,292 - $2,750	-24 Reduced 0.06%	39,335 $3.81 Million
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $12,295 - $13,699	-122 Reduced 0.31%	39,359 $4.29 Million
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $31,963 - $37,623	-330 Reduced 0.83%	39,481 $4 Million
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $380 - $446	4 Added 0.01%	39,811 $0
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $3,580 - $4,145	-37 Reduced 0.09%	39,807 $3.85 Million
Q2 2022 Aug 04, 2022	BUY	$102.07 - $123.37 $306 - $370	3 Added 0.01%	39,844 $4.33 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $401,350 - $489,420	-3,520 Reduced 8.12%	39,841 $4.72 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $133,321 - $163,244	-1,154 Reduced 2.59%	43,361 $6.1 Million
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $16,099 - $17,810	-138 Reduced 0.31%	44,515 $5.26 Million
Q2 2021 Jul 27, 2021	SELL	$105.79 - $124.53 $285,209 - $335,732	-2,696 Reduced 5.69%	44,653 $5.18 Million
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $16,652 - $19,619	-153 Reduced 0.32%	47,349 $5.67 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $102,165 - $111,330	973 Added 2.09%	47,502 $5.2 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $27,033 - $32,830	-295 Reduced 0.63%	46,529 $5.06 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $324,197 - $414,932	-4,234 Reduced 8.29%	46,824 $4.28 Million
Q1 2020 Apr 27, 2020	SELL	$62.82 - $91.86 $75,698 - $110,691	-1,205 Reduced 2.31%	51,058 $4.03 Million
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $280,202 - $311,930	-3,569 Reduced 6.39%	52,263 $4.54 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $20,951 - $22,717	-256 Reduced 0.46%	55,832 $4.67 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $68,871 - $80,325	-945 Reduced 1.66%	56,088 $4.72 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $20,197 - $24,418	305 Added 0.54%	57,033 $4.56 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $163,572 - $185,303	-2,495 Reduced 4.21%	56,728 $4.1 Million
Q3 2018 Oct 22, 2018	BUY	$60.81 - $73.36 $304 - $366	5 Added 0.01%	59,223 $4.34 Million
Q2 2018 Jul 23, 2018	SELL	$57.57 - $63.54 $5,411 - $5,972	-94 Reduced 0.16%	59,218 $3.61 Million
Q1 2018 Apr 26, 2018	BUY	$56.27 - $63.62 $9,003 - $10,179	160 Added 0.27%	59,312 $3.55 Million
Q4 2017 Jan 23, 2018	BUY	$53.68 - $57.47 $6,280 - $6,723	117 Added 0.2%	59,152 $3.38 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $2.84 Million - $3.17 Million	59,035	59,035 $3.15 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.

Account

Duncker Streett & CO Inc Abbott Laboratories Transaction History